SEARCH

SEARCH BY CITATION

References

  • 1
    American Educational Research Association APA, National Research Council on Measurement in Education. Standards for Educational and Psychological Testing. Washington, DC: AERA, 1999.
  • 2
    Nunnally JC, Bernstein I. Psychometric Theory (2nd ed.). New York: McGraw-Hill Book Company, 1978.
  • 3
    Cook DA, Beckman TJ. Current concepts in validity and reliability for psychometric instruments: theory and application. Am J Med 2006;119:166.e716.
  • 4
    Frost MH, Reeve BB, Liepa AM, et al. What is sufficient evidence for the reliability and validity of patient-reported outcome measures? Value Health 2007;10(Suppl. 2):S94105.
  • 5
    Haynes S, Richard DC, Kubany ES. Content validity in psychological assessment: a functional approach to concepts and methods. Psychol Assess 2005;7:23847.
  • 6
    FDA. Food and Drug Administration draft guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims. Federal Register 2006.
  • 7
    FDA. Food and Drug Administration draft target product file—a strategic development process tool. Federal Register 2007.
  • 8
    Delasko J, Cocchetto DM, Burke LB. Target product profile: beginning drug development with the end in mind. UPDATE 2005;January/February.
  • 9
    Turner RR, Quittner AL, Parasuraman BM, et al. Patient-reported outcomes: instrument development and selection issues. Value Health 2007;10(Suppl. 2):S8693.
  • 10
    Burke LB, Kennedy DL, Miskala PH, et al. The use of patient-reported outcome measures in the evaluation of medical products for regulatory approval. Clin Pharmacol Ther 2008;84:2813.
  • 11
    Patrick DL, Burke LB, Powers JH, et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 2007;10(Suppl. 2):S12537.
  • 12
    Revicki DA, Gnanasakthy A, Weinfurt K. Documenting the rationale and psychometric characteristics of patient reported outcomes for labeling and promotional claims: the PRO Evidence Dossier. Qual Life Res 2007;16:71723.
  • 13
    Malterud K. Qualitative research: standards, challenges, and guidelines. Lancet 2001;358:4838.
  • 14
    Cohen D, Crabtree B. Qualitative Research Guidelines Project. Available from: http://www.qualres.org/index.html[Accessed December 23, 2008.
  • 15
    Snyder C, Watson ME., Jackson JD, et al. The Mayo/FDA patient-reported outcome instrument selection: designing a measurement strategy. Value Health 2007;10:S7685.
  • 16
    Coons S, Gwaltney CJ, Hays RD, et al. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO good research practices task force report. Value Health 2009;12:41929.
  • 17
    Wild D, Eremenco S, Mear I, et al. Multinational trials—recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: the ISPOR patient reported outcomes translation & linguistic validation good research practices task force report. Value Health 2009;12:43040.